Delivery Order SPE2DB20D7066-SPE2DB26FC1LB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,010.16 to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 mL (5 mL vials) on July 30, 2025, with completion scheduled for July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- On August 11, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml vials with a ceiling value of $27,745.17. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Betamethasone SP-AC 30 mg/5 ml in 5 ml vials, with a ceiling value of $3,761.85 and a firm fixed price structure. The award was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and the product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $56,941.56 with an ultimate completion date of August 20, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Betamethasone SP-AC 30 mg/5 mL in 5 mL quantities, with a ceiling value of $4,992.01. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The contract utilizes no set-aside designation, indicating it was awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials. This contract, valued at $42,340.61, represents a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The ultimate completion date is set for September 4, 2025, with performance occurring at AmerisourceBergen's corporate...
- This federal contract award, with the ID SPE2DX15D1053|SPE2DX24F6TJF, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,583.35 firm fixed price delivery order is for the supply of 4565747880 - BETAMETHASONE SP-AC 30 MG/5 ML 5ML, a pharmaceutical product. The contract has an ultimate completion date of September 11, 2024 and was awarded on September 10, 2024. This delivery order is part of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Betamethasone SP-AC 30 mg/5 ml, a pharmaceutical product, with a ceiling value of $40,708.85. The delivery order has a firm fixed price and is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of July 2, 2025. AmerisourceBergen Drug Corp is...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,883.43 firm-fixed-price contract is for the delivery of betamethasone sodium phosphate, a corticosteroid medication, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 16, 2025, for the supply of Betamethasone SP-AC 30mg, a corticosteroid medication. This non-competitive, firm fixed-price delivery order carries a ceiling value of $1,683.60 and is scheduled for completion by October 17, 2025. The vendor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1LBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,410.75 to AmerisourceBergen Drug Corp for the supply of Betamethasone SP-AC 30 mg/5 ml in 5 ml vials. This competitive award, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, generic drugs, vaccines, and specialized medical supplies. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements through its extensive portfolio of competitive contract awards with the DLA Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/24/25 |